Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Change in Cash (2016 - 2025)

Orthofix Medical (OFIX) has disclosed Change in Cash for 16 consecutive years, with $19.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Cash fell 63.96% year-over-year to $19.2 million, compared with a TTM value of -$623000.0 through Dec 2025, down 101.3%, and an annual FY2025 reading of -$623000.0, down 101.3% over the prior year.
  • Change in Cash was $19.2 million for Q4 2025 at Orthofix Medical, up from -$2.7 million in the prior quarter.
  • Across five years, Change in Cash topped out at $53.2 million in Q4 2024 and bottomed at -$25.3 million in Q1 2025.
  • Average Change in Cash over 5 years is -$585300.0, with a median of -$1.4 million recorded in 2021.
  • The sharpest move saw Change in Cash tumbled 1032.92% in 2024, then soared 1477.26% in 2025.
  • Year by year, Change in Cash stood at $4.6 million in 2021, then plummeted by 120.73% to -$960000.0 in 2022, then skyrocketed by 526.46% to $4.1 million in 2023, then surged by 1199.07% to $53.2 million in 2024, then plummeted by 63.96% to $19.2 million in 2025.
  • Business Quant data shows Change in Cash for OFIX at $19.2 million in Q4 2025, -$2.7 million in Q3 2025, and $8.2 million in Q2 2025.